Matches in Wikidata for { <http://www.wikidata.org/entity/Q42723815> ?p ?o ?g. }
- Q42723815 description "2011 nî lūn-bûn" @default.
- Q42723815 description "2011年の論文" @default.
- Q42723815 description "2011年論文" @default.
- Q42723815 description "2011年論文" @default.
- Q42723815 description "2011年論文" @default.
- Q42723815 description "2011年論文" @default.
- Q42723815 description "2011年論文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011年论文" @default.
- Q42723815 description "2011년 논문" @default.
- Q42723815 description "article científic" @default.
- Q42723815 description "article scientific" @default.
- Q42723815 description "article scientifique" @default.
- Q42723815 description "articol științific" @default.
- Q42723815 description "articolo scientifico" @default.
- Q42723815 description "artigo científico" @default.
- Q42723815 description "artigo científico" @default.
- Q42723815 description "artigo científico" @default.
- Q42723815 description "artikel ilmiah" @default.
- Q42723815 description "artikull shkencor" @default.
- Q42723815 description "artikulong pang-agham" @default.
- Q42723815 description "artykuł naukowy" @default.
- Q42723815 description "artículo científico publicado en 2011" @default.
- Q42723815 description "artículu científicu espublizáu en 2011" @default.
- Q42723815 description "bilimsel makale" @default.
- Q42723815 description "bài báo khoa học" @default.
- Q42723815 description "naučni članak" @default.
- Q42723815 description "scienca artikolo" @default.
- Q42723815 description "scientific article published on 16 November 2011" @default.
- Q42723815 description "scientific article published on 16 November 2011" @default.
- Q42723815 description "scientific article published on 16 November 2011" @default.
- Q42723815 description "teaduslik artikkel" @default.
- Q42723815 description "tieteellinen artikkeli" @default.
- Q42723815 description "tudományos cikk" @default.
- Q42723815 description "vedecký článok" @default.
- Q42723815 description "vetenskaplig artikel" @default.
- Q42723815 description "videnskabelig artikel" @default.
- Q42723815 description "vitenskapelig artikkel" @default.
- Q42723815 description "vitskapeleg artikkel" @default.
- Q42723815 description "vědecký článek" @default.
- Q42723815 description "wetenschappelijk artikel" @default.
- Q42723815 description "wissenschaftlicher Artikel" @default.
- Q42723815 description "επιστημονικό άρθρο" @default.
- Q42723815 description "мақолаи илмӣ" @default.
- Q42723815 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q42723815 description "научна статия" @default.
- Q42723815 description "научная статья" @default.
- Q42723815 description "научни чланак" @default.
- Q42723815 description "научни чланак" @default.
- Q42723815 description "מאמר מדעי" @default.
- Q42723815 description "مقالة علمية نشرت في 16 نوفمبر 2011" @default.
- Q42723815 description "১৬ নভেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q42723815 description "บทความทางวิทยาศาสตร์" @default.
- Q42723815 description "სამეცნიერო სტატია" @default.
- Q42723815 name "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 name "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 type Item @default.
- Q42723815 label "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 label "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 prefLabel "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 prefLabel "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 P1433 Q42723815-EF9F5A6A-62FF-4657-A13F-A91885B7CBD6 @default.
- Q42723815 P1476 Q42723815-6B269144-B472-442E-9076-984CCBEAEF21 @default.
- Q42723815 P2093 Q42723815-0A9C362F-9413-4AC6-8AF5-E5628F9B733E @default.
- Q42723815 P2093 Q42723815-179EA5E2-347D-43AE-A79C-E548F5CF1173 @default.
- Q42723815 P2093 Q42723815-18E5CB94-594D-4C5B-AC95-6E39F75CE3AB @default.
- Q42723815 P2093 Q42723815-2C268B51-CBD2-41B6-B6C5-8BE086891D3C @default.
- Q42723815 P2093 Q42723815-7E0CD594-0515-4CD9-BD7F-DA89044068F6 @default.
- Q42723815 P2093 Q42723815-A7B6767C-B0D1-4E19-BD04-350F50445709 @default.
- Q42723815 P2093 Q42723815-EC557439-41B5-4CAA-8070-912AF39596D3 @default.
- Q42723815 P2093 Q42723815-F759EDF5-4BEE-4650-811F-9B9F3645FACF @default.
- Q42723815 P304 Q42723815-670E8C8B-41DA-4BC6-B153-204126DF2269 @default.
- Q42723815 P31 Q42723815-796E0246-D401-4A9E-ABC5-C77E42583EC0 @default.
- Q42723815 P356 Q42723815-DF8CDE96-B9F8-4507-8E2A-C8D8E094499E @default.
- Q42723815 P407 Q42723815-C712ACA4-6D60-49D5-A8E1-FE3BA0B05A18 @default.
- Q42723815 P433 Q42723815-3A9F18F0-79C9-48A4-9D60-A3F0B6F4969C @default.
- Q42723815 P478 Q42723815-289C4E95-6241-4BD8-BEC5-63BE8208A228 @default.
- Q42723815 P50 Q42723815-1C0BB64C-E5A6-45A4-9A5B-FEE413EB7CD5 @default.
- Q42723815 P50 Q42723815-43497BD8-A525-4807-B955-BAFB8D30A176 @default.
- Q42723815 P577 Q42723815-103AC4CF-8C2F-4520-9FE0-484B7A9C2C0E @default.
- Q42723815 P698 Q42723815-AAB6A868-7D42-4FC7-956A-79CA76F51CB0 @default.
- Q42723815 P921 Q42723815-605F4F5D-E49F-4DDA-8024-A55EDDA6A1C9 @default.
- Q42723815 P921 Q42723815-AACE5B53-2497-4EC6-8720-613D4859EF4F @default.
- Q42723815 P356 1078-0432.CCR-11-0509 @default.
- Q42723815 P698 22090362 @default.
- Q42723815 P1433 Q332253 @default.
- Q42723815 P1476 "Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer" @default.
- Q42723815 P2093 "Angela Demichele" @default.
- Q42723815 P2093 "Gary K Schwartz" @default.
- Q42723815 P2093 "M Naveed Shaik" @default.
- Q42723815 P2093 "Patricia M Lorusso" @default.
- Q42723815 P2093 "Peter J O'Dwyer" @default.
- Q42723815 P2093 "Rachel Courtney" @default.
- Q42723815 P2093 "Sophia S Randolph" @default.
- Q42723815 P2093 "Vandana G Abramson" @default.
- Q42723815 P304 "568-576" @default.